FIRST‐LINE THERAPY WITH RITUXIMAB VERSUS RITUXIMAB‐CHOP IN POST‐TRANSPLANT MONOMORPHIC DIFFUSE LARGE B‐CELL LYMPHOMA: A LARGE SERIES FROM SPANISH GROUP OF LYMPHOMA (GELTAMO) | Publicación